Loading...
A Case of Lung Adenocarcinoma with Marked Improvement of Pulmonary Lymphangitic Carcinomatosis by Adding Bevacizumab to Cisplatin and Pemetrexed
A 40-year-old man with a diagnosis of lung adenocarcinoma (cT4N3M1c, stage IVB) experienced worsening of lymphangitic carcinomatosis in the right lung and right pleural effusion after receiving 1 cycle of first-line chemotherapy consisting of cisplatin and pemetrexed. Bevacizumab was thus added from...
Na minha lista:
| Udgivet i: | Case Rep Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5836232/ https://ncbi.nlm.nih.gov/pubmed/29515397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000484662 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|